Michael Gelband’s NeoGenomics NEO Stock Holding History

Michael Gelband’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13M	Buy	+214,449	New	+$2.07M	0.02%	649
2026 Q1	–	Sell	-16,718	Closed	-$197K	–	1910
2025 Q4	$197K	Buy	+16,718	New	+$180K	﹤0.01%	1389
2025 Q3	–	Sell	-320,625	Closed	-$2.34M	–	1857
2025 Q2	$2.34M	Buy	+320,625	New	+$2.59M	0.02%	684
2023 Q1	–	Sell	-12,691	Closed	-$117K	–	2005
2022 Q4	$117K	Sell	12,691 -17,036	-57%	-$159K	﹤0.01%	1510
2022 Q3	$256K	Sell	29,727 -7,605	-20%	-$75.5K	﹤0.01%	1567
2022 Q2	$304K	Buy	37,332 +18,631	+100%	+$178K	﹤0.01%	1531
2022 Q1	$227K	Buy	+18,701	New	+$394K	﹤0.01%	1858
2019 Q4	–	Sell	-18,100	Closed	-$346K	–	1757
2019 Q3	$346K	Buy	+18,100	New	+$425K	0.01%	823

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Michael Gelband's NEO Position: Q2 2026 in Review

Michael Gelband opened a new position in NeoGenomics (NEO) in Q2 2026: 214,449 shares worth $3.13M. The stake represents 0.02% of the portfolio and ranks #649 among its holdings. This is a return to the name: Michael Gelband previously reported a position in NEO as recently as Q4 2025.

Michael Gelband first reported a position in NEO in Q3 2019 and has held it in 8 quarters since. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Michael Gelband held 214,449 shares of NeoGenomics worth $3.13M as of Q2 2026.
NeoGenomics was a new Michael Gelband position in Q2 2026.
NeoGenomics made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #649 holding.
Michael Gelband first reported a position in NeoGenomics in Q3 2019 and has held it in 8 quarters since.
265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.